Corinfar (nifedipine) retard tablets with prolonged release 20 mg. №50 vial

$30.60

Manufacturer: Croatia

Purpose: Nifedipine relaxes blood vessels, treats high blood pressure, angina, and Raynaud’s.

SKU: MED57452 Category:

Description

Corinfar (Nifedipine) Retard Tablets with Prolonged Release 20 mg

Ingredients

Active ingredient: Nifedipine 20 mg.

Other ingredients: lactose monohydrate, cellulose microcrystalline, colloidal anhydrous silica, magnesium stearate.

Dosage

Adults: The usual dose is one tablet every 12 hours. Dosage may vary based on individual response. Consult a healthcare professional for personalized recommendations.

Indications

Corinfar (Nifedipine) Retard Tablets are indicated for hypertension and angina pectoris treatment.

Contraindications

Do not use if:

  • You are allergic to nifedipine or any other ingredients.
  • You have severe hypotension.
  • You are pregnant or breastfeeding without medical advice.

Directions

Take as directed by your healthcare provider. Swallow whole with water. Do not crush or chew.

Scientific Evidence

Nifedipine, a calcium channel blocker, relaxes blood vessels, improving blood flow and reducing pressure. Studies support its efficacy in hypertension and angina management. Research in the Journal of Hypertension shows long-term cardiovascular benefits.

Additional Information

Follow prescribed dosage to avoid adverse effects. Inform about other medications. Regular monitoring is essential during treatment.

Corinfar (Nifedipine) Retard Tablets provide effective treatment for hypertension and angina by maintaining consistent drug levels, aiding blood pressure control and angina frequency reduction. Clinical trials confirm sustained efficacy, making it a trusted choice.

Nifedipine blocks calcium channels in smooth muscle, causing vasodilation and reduced resistance. This enhances oxygen delivery to the heart, reducing workload and managing angina and hypertension. Compared to other blockers, its prolonged-release offers consistent effects, improving compliance and outcomes.